Sat.May 14, 2022 - Fri.May 20, 2022

Scientists home in on cause of Duchenne gene therapy side effect

Bio Pharma Dive

An unusual collaboration among gene therapy developers suggests certain mutations could be behind "peculiar" side effects experienced by several patients treated in clinical trials

Lilly has a new blockbuster

World of DTC Marketing

If You’re Short On Time: The U.S. Food and Drug Administration approved Eli Lilly’s novel treatment for diabetes. The drug led to impressive blood sugar and body weight drops in clinical trials.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Study links thalamus inhibition in adolescence to long-lasting cortical abnormalities


A team of Columbia University researchers has reported new evidence that cognitive abnormalities seen in neuropsychiatric disorders such as schizophrenia may be traceable to altered activity in the thalamus during adolescence, a time window of heightened vulnerability for schizophrenia.

Breakthroughs in Clinical Research

Riverside Clinical Research

Clinical research enables doctors and researchers to develop a better understanding of diseases.

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

AbbVie asks FDA to approve Parkinson's treatment

Bio Pharma Dive

The company believes the treatment, which uses prodrug versions of two commonly used Parkinson's medications, could be a longer-lasting option for patients and blockbuster product for AbbVie

A new era of pharma marketing?

World of DTC Marketing

Just 13% of people trust the pharma companies they interact with. 68% say the interactions feel transactional. Only a third agree that organizations know their communication preferences.

More Trending

New patent for Ironwood Pharms drug DUZALLO

Drug Patent Watch

Annual Drug Patent Expirations for DUZALLO Duzallo is a drug marketed by Ironwood Pharms Inc and is included in one NDA. There are nine patents protecting this drug. DUZALLO drug…. The post New patent for Ironwood Pharms drug DUZALLO appeared first on DrugPatentWatch - Make Better Decisions.

Seagen CEO Siegall resigns amid domestic violence investigation

Bio Pharma Dive

The biotech company is searching for a permanent successor to Siegall, who was arrested last month for alleged domestic violence. CMO Roger Dansey will continue as interim CEO


Moderna’s HIV vaccine prepped for trials in Africa

Pharma Phorum

Moderna has joined forces with non-profit organisation IAVI on a third phase 1 trial of its candidate HIV vaccine in Africa, where the burden of the virus is still being keenly felt.

Long-hypothesized ‘next generation wonder material’ created for first time


For over a decade, scientists have attempted to synthesize a new form of carbon called graphyne with limited success. That endeavor is now at an end, though, thanks to new research from the University of Colorado Boulder.

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

Artificial intelligence stands to transform precision medicine: AiCure

Outsourcing Pharma

An expert from the AI-focused technology company shares insights as to how it can be harnessed to better interpret, and even predict, patient behavior. Patient centricity

PTC's first gene therapy gains European regulator's backing

Bio Pharma Dive

The brain-infused treatment for a rare neurological disease would be one of only three gene therapies commercially available in the EU. PTC plans to ask for FDA approval later this year

Google gives ex-FDA digital health head Bakul Patel strategic role

Pharma Phorum

FDA veteran Bakul Patel has joined Google as its new senior director of global digital health strategy, ending a stint at the regulator that lasted more than 13 years. Bakul Patel.

Electrons in a crystal exhibit linked and knotted quantum twists


As physicists delve deeper into the quantum realm, they are discovering an infinitesimally small world composed of a strange and surprising array of links, knots and winding. Some quantum materials exhibit magnetic whirls called skyrmions — unique configurations described as “subatomic hurricanes.”


Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

Machine learning can unlock potential of EEG data: Beacon Biosignals

Outsourcing Pharma

A leader from the neurobiomarker platform provider tells how use of ML and other advanced analytical tools can help make better use of complex information. Clinical Development

Gilead, having resolved manufacturing issues, forges ahead with HIV drug

Bio Pharma Dive

The company can now resume testing in nearly a dozen studies that were paused due to FDA concerns about interactions between the drug, lenacapavir, and the glass vials in which it was contained

New patent for Genentech Inc drug ESBRIET

Drug Patent Watch

Annual Drug Patent Expirations for ESBRIET Esbriet is a drug marketed by Genentech Inc and is included in two NDAs. It is available from one supplier. There are twenty-one patents…. The post New patent for Genentech Inc drug ESBRIET appeared first on DrugPatentWatch - Make Better Decisions.

Machine learning radically reduces workload of cell counting for disease diagnosis


The use of machine learning to perform blood cell counts for diagnosis of disease instead of expensive and often less accurate cell analyzer machines has nevertheless been very labor-intensive as it takes an enormous amount of manual annotation work by humans in the training of the machine learning model.

Large UK study suggests vaccination helps treat long COVID

Pharma Phorum

Ultragenyx strikes deal with struggling Abeona for rare disease gene therapy

Bio Pharma Dive

The treatment, which is designed to treat Sanfilippo syndrome, could become Ultragenyx's first gene therapy to reach market in the U.S., according to the biotech's CEO

New patent for Ironwood Pharms drug ZURAMPIC

Drug Patent Watch

Annual Drug Patent Expirations for ZURAMPIC Zurampic is a drug marketed by Ironwood Pharms Inc and is included in one NDA. There are nine patents protecting this drug. This drug…. The post New patent for Ironwood Pharms drug ZURAMPIC appeared first on DrugPatentWatch - Make Better Decisions.

Engineers evaluate the factors behind battery performance at low temperatures


Energy storage with rechargeable battery technologies powers our digital lifestyles and supports renewable energy integration into the power grid. However, battery function under cold conditions is an ongoing challenge, motivating research on improving low temperature performance of batteries.

Sleepio app for insomnia backed by NICE

Pharma Phorum

After a non-committal appraisal of Big Health’s Sleepio app for insomnia last November in draft guidance from NICE, the cost-effectiveness agency has come out in favour of the digital therapy.

Bayer backs out of Atara cell therapy deal

Bio Pharma Dive

The German drugmaker will hand back rights to two CAR-T cell therapies it was developing with Atara, which said it would reassess its strategy for the programs

University of California at Irvine launches Institute for Precision Health

Outsourcing Pharma

The institute will combine the universityâs AI, ML, health science, engineering, genomics, and data capabilities to tackle health strategy and inequity. Patient centricity

Research brings hope for spinal cord injury treatment


Scientists from the University of Birmingham have shown an existing drug may reduce damage after spinal cord injury, by blocking the inflammatory response in the spinal cord.

USAID on expanding digital health globally – part one

Pharma Phorum

Adele Waugaman, senior digital health coordinator of the COVID-19 response at the United States Agency for International Development (USAID), tells us what the agency focuses on to strengthen digital health infrastructure globally and improve and expand healthcare access.

Making sub-visible particles visible

Bio Pharma Dive

Sub-visible particles can lower the effectiveness of a drug, which is why regulatory authorities are demanding processes be developed, validated and set up in such a way as to minimize all forms of contamination

MHRA marketing authorisation granted for Eli Lilly’s Verzenios as early breast cancer treatment

Pharma Times

Authorisation of the treatment is based on results from the phase 3 trial

Snake trade in Indonesia is not sustainable enough — but it could be


Wildlife trade is a multi-million dollar industry. While some animals are traded legally, in compliance with legislation that aims to protect populations, wildlife trafficking continues to thrive in many places, threatening precious species with extinction.

Lilly’s new drug Mounjaro (tirzepatide ) wins US FDA approval

Pharma Phorum

Blood sugar control drug Mounjaro has been granted US regulatory approval, giving type 2 diabetics another way to help keep their glucose levels in check.

Why choosing the right primary container is crucial

Bio Pharma Dive

New mRNA technology: identifying the right drug containment solution is more important than ever

NIH awards $577m to antiviral drug developers

BioPharma Reporter

The National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health, has awarded a total of $577m to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern. Drug Delivery

Research sheds light on crimean-congo hemorrhagic fever disease process


Army scientists determined that the body’s own natural immune response contributes to disease severity in mice infected with Crimean-Congo hemorrhagic fever virus (CCHFV), which causes a widespread tick-borne viral infection in humans.